Dr. Kenton Gregory is the Founding Director of the Oregon Health & Science University (OHSU) Center for Regenerative Medicine and a Professor in the OHSU Department of Biomedical Engineering. He is a clinician/scientist/engineer with a 25-year history of creating and managing successful multi-disciplinary, multi-institutional research and development programs where he has advanced concepts of diagnostics and cures to civilians and battlefield deployment of life-saving technologies. Dr. Gregory has been a focus/program leader for the Armed Forces Institute for Regenerative Medicine (AFIRM) for the past 8 years.
Dr. Gregory received his undergraduate degree in chemical engineering and doctorate in medicine from the University of Southern California. He has held teaching positions at the University of California Irvine Medical School, Harvard University School of Medicine, and OHSU. Dr. Gregory is a Fellow of the American College of Cardiology, Fellow of the American Institute of Biomedical Engineering, and an Intellectual Ventures Laboratory Fellow. Dr. Gregory is a practicing cardiologist.
At the OHSU Center for Regenerative Medicine, Dr. Gregory is the PI initiating a First-In-Man FDA Clinical Trial for the Use of Autologous Bone Marrow Mononuclear Cells to Treat Severe Extremity Injury. He also leads regenerative medicine research efforts for the use of adult stem and progenitor cells for heart, skin, nerve, spinal cord, and vascular regeneration as well as the use of cells to treat acute respiratory distress syndrome in DOD and DARPA supported research.
He holds more than 40 domestic and international patents and has served as principal investigator on six FDA-sponsored clinical trials. Dr. Gregory has launched seven spin-off companies since 1991 based upon his inventions.
View a list of Dr. Gregory’s publications here.